Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Conclusion:DCE-MRI especially pretreatment Ktrans can potentially predict the treatment response to neoadjuvant chemotherapy for hypopharyngeal cancer.Advances in knowledge:Few studies of DCE-MRI on hypopharyngeal cancer treated with chemoradiation reported. The results demonstrate that DCE-MRI especially pretreatment Ktrans may be more potential value in predicting the treatment response to neoadjuvant chemotherapy for hypopharyngeal cancer.
PMID: 32915647 [PubMed - as supplied by publisher]
Source: The British Journal of Radiology - Category: Radiology Authors: Guo W, Zhang Y, Luo D, Yuan H Tags: Br J Radiol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Hypopharyngeal Cancer | MRI Scan | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Radiology | Study | UK Health